Myelosuppressive therapies significantly increase pro‐inflammatory cytokines and directly cause bone loss
This article is protected by copyright. All rights reserved
Source: Journal of Bone and Mineral Research - Category: Orthopaedics Authors: Julie M. Quach, Maria Askmyr, Tanja Jovic, Emma K. Baker, Nicole C. Walsh, Simon J. Harrison, Paul Neeson, David Ritchie, Peter R. Ebeling, Louise E. Purton Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Orthopaedics | Reclast | Stem Cell Therapy | Stem Cells | Study | Transplants | Zometa